Q3: Reckitt India maintains growth momentum despite GST impact

The company noted that like-for-like net revenue growth in India stayed in high single digits

by e4m Staff
Published: Oct 22, 2025 3:34 PM | 2 min read

Reckitt reported steady momentum in India during the third quarter of 2025, with sell-out growth remaining strong even as a GST regime change in September temporarily affected trade orders. The company noted that like-for-like net revenue growth in India stayed in high single digits for the year to date. Key categories such as Germ Protection and Intimate Wellness continued to perform well, led by Dettol, Harpic, and Durex. India remains a strong growth engine within Reckitt’s Emerging Markets portfolio, which posted 15.5% like-for-like growth in Q3.

Globally, Reckitt delivered a solid performance with group like-for-like net revenue up 7% in Q3, driven by strong gains in Core Reckitt and a 22% surge in Mead Johnson Nutrition. Emerging Markets led growth, offsetting softness in developed markets. The company reaffirmed its full-year 2025 guidance, expecting Core Reckitt’s net revenue growth above 4%.

Commenting on the results, Chief Executive Officer Kris Licht stated, “We have delivered a strong third-quarter performance with LFL net revenue up 6.7% in Core Reckitt. These results reflect sequential volume improvements and the strength of our Powerbrands. We returned to growth in Developed Markets against a challenging consumer landscape and continued to deliver outsized growth in Emerging Markets. With our sharpened operating structure, we are executing our plan and progressing our strategic objectives to be a world-class consumer health and hygiene company. We are pleased with our performance and we are confident in delivering our full year 2025 guidance.”